Leyre Zubiri
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 38
- Colorectal Cancer Treatments and Studies 16
- COVID-19 and healthcare impacts 7
- CAR-T cell therapy research 6
- Pancreatic and Hepatic Oncology Research 4
- Cancer Research top 10%
- Immunology top 10%
- Internal Medicine top 10%
-
- Lung Cancer Treatments and Mutations 5
-
- Chronic Lymphocytic Leukemia Research 4
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Kerry L. ReynoldsRyan J. SullivanÁlvaro GonzálezJosé Luis Perez‐GraciaSalvador Martín‐AlgarraMeghan J. MooradianTomas G. NeilanDaniel A. Zlotoff
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Circulation (3 papers)Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- United StatesSpainHungary
In The Last Decade
Leyre Zubiri
52 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.3k
- Cancer Research 287
- Immunology 329
- Internal Medicine 57
- Pulmonary and Respiratory Medicine 450
Countries citing papers authored by Leyre Zubiri
This map shows the geographic impact of Leyre Zubiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyre Zubiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyre Zubiri more than expected).
Fields of papers citing papers by Leyre Zubiri
This network shows the impact of papers produced by Leyre Zubiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyre Zubiri. The network helps show where Leyre Zubiri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leyre Zubiri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 34 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 53 | |
| 6 | 2022 | 28 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 20 | |
| 11 | Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis | 2020 | 1 |
| 12 | 2020 | 43 | |
| 13 | 2020 | 49 | |
| 14 | 2019 | 205 | |
| 15 | 2019 | 49 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 28 | |
| 18 | 2015 | 134 | |
| 19 | 2015 | 31 | |
| 20 | 2013 | 21 |
About Leyre Zubiri
Leyre Zubiri is a scholar working on Oncology, Genetics and Transplantation, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (38 papers), Colorectal Cancer Treatments and Studies (16 papers), COVID-19 and healthcare impacts (7 papers), CAR-T cell therapy research (6 papers), Lung Cancer Treatments and Mutations (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (287 citations) and Immunology (329 citations). Leyre Zubiri has collaborated with scholars based in United States, Spain and Hungary. Frequent co-authors include Kerry L. Reynolds, Ryan J. Sullivan, Álvaro González, José Luis Perez‐Gracia, Salvador Martín‐Algarra, Meghan J. Mooradian, Tomas G. Neilan, Daniel A. Zlotoff, Meghan E. Sise and Hannah Gilman. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.